Coordination - management - training - public relations

KFO第一阶段的经验表明，临床研究单位在很大程度上依赖于来自基础和临床研究不同学科的参与研究小组之间的合作和互动。如果合作协调得好，公共资源就可以共享和使用，这在很大程度上构成了这样一个联合体的附加值。因此，TP9的主要目标之一将是协调已规划的研究项目，协调在KFO第一阶段形成的交流平台的未来发展，并加强数据和结果的交流，以产生新的假设并将其转化为实验研究。特别是，我们将努力促进翻译方法，使血小板生物学更接近临床应用。此外，TP 9还为年轻研究人员组织培训、教学和交流计划，并为KFO组织会议和会议，我们还将邀请外部演讲者参加。此外，TP 9整合并致力于进一步扩展患者数据库及其与现有电子患者记录的交叉连接，组织和提供具有中央服务(动物模型)的不同TPS，以及关于KFO的公共关系(主页，虚拟管理)。我们设法争取到Klaus Ley教授(科长和教授；自身免疫研究；炎症生物学，La Jolla)作为整合在KFO中的墨卡托教授的潜在任命，如果DFG批准的话。雷教授在血小板功能及其与组织和血管炎症的相关性方面是一位著名的专家。莱伊教授的墨卡托教授职位在KFO第二阶段的实施最终将推动财团的发展，因为他是一位国际知名的研究人员，他的参与将明显提高我们KFO 274的国际知名度。

The previous experience during the first period of the KFO showed that a clinical research unit largely depends on cooperations and interactions in between the participating research groups coming from different disciplines of basic and clinical research. If the cooperations are well coordinated, common resources can be shared and used, which constitutes to a large extent the added value of such a consortium. One of the main goals of TP9, thus, will be coordination of the planned research projects, the future development of communication-platforms formed during the first period of the KFO and to intensify exchange of data and results to generate novel hypotheses and to transfer those into experimental studies. Particularly, we will try to promote translational approaches to bring platelet biology closer to clinical applications. TP 9 furthermore organizes training-, teaching and exchange programs for young researchers and meetings and conferences for the KFO, for which we will also invite speakers from outside. Moreover, TP 9 integrates and works on further extension of the patients database and its crosslinking with the existing electronic patient record, the organisation of and supply of the different TPs with central services (animal models) and the public relations concerning the KFO (homepage, virtual administration). We managed to aquire Prof. Klaus Ley (Division Head und Professor; Autoimmune Research; Inflammation Biology, La Jolla) for a potential appointment as Mercator-Professor integrated in the KFO, if granted by the DFG. Prof. Ley is a renowned expert in the area of platelet function and their relevance to tissue- and vascular inflammation. The implementation of the Mercator-Professorship for Prof. Ley in the 2nd period of the KFO will eventually advance the consortium as he is an internationally respected researcher and his participation will clearly increase the international visibility of our KFO 274.